About Unimarck Pharma
Unimarck Pharma is a Healthcare company based in Mohali (India) founded in 1984. Pharmaceutical manufacturing and services in India focusing on ethical, generic, and cosmoceutical divisions. The company has 409 employees. Its Indian entity Unimarck Pharma (India) Limited reported revenue of ₹58.24 Cr. Unimarck Pharma offers products and services including Ethical Pharmaceuticals and Generic Pharmaceuticals. Its focus areas include Pharmaceuticals, Generic Pharmaceuticals, Generic Drug Distribution and Ethical Pharmaceuticals.
Company details
Unimarck Pharma has been established in the pharmaceutical industry since 1984, with a benchmark set for quality and commitment to human well-being. Divisions including Ethical, Generic, Cosmoceutical, and Contract Manufacturing are operated to deliver comprehensive pharmaceutical offerings. Certifications such as WHO, GLP, GMP, and ISO are maintained to ensure global standards compliance. Founded by Mr. Bhupinder Pal Singh Bhatia, the company is recognized for its innovative research and state-of-the-art facilities in India, contributing to health advancements over four decades.
- Headquarters Mohali, India
- Employees 409
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website unimarckpharma.com
- Social LinkedIn X Facebook Instagram YouTube
- Legal Name Unimarck Pharma (India) Limited
- Date of Incorporation 12 Mar, 1984
- Jurisdiction Chandigarh, India
- Annual Revenue₹58.24 Cr
FY 2025 · +7% YoY
- Net Loss-₹58.4 Lakh
FY 2025 · -1% margin
- EBITDA₹2.00 Cr
FY 2025 · 3% margin
- Employee Count409
Associated legal entities of Unimarck Pharma
Unimarck Pharma operates through Unimarck Pharma (India) Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Unimarck Pharma (India) Limited CIN U24232CH1984PLC005768 | Active | 12 Mar 1984 | Chandigarh, Chandigarh | ₹58.2 Cr | 409 | 4 | View details |
Products & Services of Unimarck Pharma
Unimarck Pharma offers a comprehensive portfolio of products and services, including Ethical Pharmaceuticals and Generic Pharmaceuticals.
Ethical pharmaceuticals are manufactured and supplied through dedicated divisions to meet healthcare needs.
Generic pharmaceuticals are produced and distributed to provide affordable medication options.
Apps and channels of Unimarck Pharma
its YouTube channel Unimarck Pharma India Ltd has 165 subscribers and 4 videos.
Videos from Unimarck Pharma
The most watched videos on Unimarck Pharma's YouTube channel, Unimarck Pharma India Ltd (165 subscribers). Click a video to play it here.
More on Unimarck Pharma India Ltd.
Board of directors of Unimarck Pharma (India) Limited (Unimarck Pharma)
Unimarck Pharma (India) Limited is the primary company behind Unimarck Pharma. The board of Unimarck Pharma (India) Limited currently have 4 directors; the longest-serving is Harsh Bhatia, appointed in 1984. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Harsh Bhatia DIN 00659651 | Whole-time director | 12 Mar 1984 | 42 yrs 7 mo | Unimarck Pharma (India) Limited |
| Gagandeep Bhatia DIN 00660772 | Whole-time director | 10 Aug 2000 | 26 yrs 3 mo | Unimarck Pharma (India) Limited |
| Mandeep Singh DIN 01893488 | Managing Director | 03 Dec 2015 | 10 yrs 11 mo | Unimarck Pharma (India) Limited |
| Harleen Kaur Bhatia DIN 07414410 | Director | 01 Apr 2023 | 3 yrs 7 mo | Unimarck Pharma (India) Limited |
Financials of Unimarck Pharma
Figures of Unimarck Pharma (India) Limited, the primary company behind Unimarck Pharma, for FY 2025. Revenue was ₹58.24 Cr (+7% year on year). Net loss was -₹58.4 Lakh (-1% margin). EBITDA was ₹2.00 Cr (3% margin). Revenue has grown at a compounded annual rate of -5% over three years and -1% over five years.
- ₹58.24 CrRevenue · FY 2025 · +7% YoY
- -₹58.4 LakhNet loss · -1% margin
- ₹2.00 CrEBITDA · 3% margin
- ₹1.79 CrPaid-up capital
- 409Employees (provident fund records)
- -5%Revenue CAGR, 3 years
- -1%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Unimarck Pharma (India) Limited are on its company page.
Detailed financial statements for Unimarck Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Unimarck Pharma
The website of Unimarck Pharma (unimarckpharma.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 20.4% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Unimarck Pharma
Unimarck Pharma was founded in 1984.
Unimarck Pharma is headquartered in Mohali, India. It is registered at Mohali, Punjab, India.
Unimarck Pharma has 409 employees.
The primary company behind Unimarck Pharma, Unimarck Pharma (India) Limited, reported revenue of ₹58.24 Cr for FY 2025, up 7% year on year.
Unimarck Pharma has been established in the pharmaceutical industry since 1984, with a benchmark set for quality and commitment to human well-being. Divisions including Ethical, Generic, Cosmoceutical, and Contract Manufacturing are operated to deliver comprehensive pharmaceutical offerings. Certifications such as WHO, GLP, GMP, and ISO are maintained to ensure global standards compliance. Founded by Mr. Bhupinder Pal Singh Bhatia, the company is recognized for its innovative research and state-of-the-art facilities in India, contributing to health advancements over four decades.
Unimarck Pharma offers Ethical Pharmaceuticals and Generic Pharmaceuticals.
Unimarck Pharma operates through Unimarck Pharma (India) Limited.
The legal entities of Unimarck Pharma currently have 4 directors, including Gagandeep Bhatia, Harleen Kaur Bhatia, Harsh Bhatia and others.